RxDoctor Payments Data

Bogdan Grigorescu, MD

Urogynecology and Reconstructive Pelvic Surgery · Mineola, NYNPI 1871673335

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $6,500 of the $7,320 with a category attached, or 88.8%. Caldera Medical, Inc accounts for 91.7% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2020 at $6,546 and has fallen 99.7% since, to $18 in 2025.

$7,320in general payments, 2019–2025

Across 12 payments — averaging $610.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Caldera Medical, Inc$7K
  • Axonics, Inc.$237
  • Coloplast$188
  • Covidien LP$78
  • Contura, Inc.$46
  • Hologic Sales And Service, LLC$43
  • plus $18 from 1 others

What the payments were for

  • Consulting fees$6,50089%
  • Food & beverage$6108%
  • Gifts$2103%

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Caldera Medical, Inc4$6,710
Axonics, Inc.2$237
Coloplast2$188
Covidien LP1$78
Contura, Inc.1$46
Hologic Sales And Service, LLC1$43
Lilly USA, LLC1$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,320 in reported general payments places this provider in the 80th percentile of 90 urogynecology and reconstructive pelvic surgery providers in New York.

See all urogynecology and reconstructive pelvic surgery providers in New York

Medicare billing

Part B allowed, 2024
$198,507
Medicare patients
458
Services billed
2,482

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
GemtesaVibegron133$154,354
MyrbetriqMirabegron85$74,098
Darifenacin ErDarifenacin Hydrobromide42$11,732
Mirabegron ErMirabegron13$10,568
Trospium Chloride ErTrospium Chloride37$8,036
Estradiol63$4,161
Methenamine Hippurate32$3,350
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst197$2,767
Trospium Chloride17$1,212
Oxybutynin Chloride ErOxybutynin Chloride33$1,090
Solifenacin Succinate12$813
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav38$240
Nystatin19$222
Fluconazole34$132
Triamcinolone Acetonide17$79

Paid to pharmacies, not to this prescriber.

Other urogynecology and reconstructive pelvic surgery in Mineola

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →